Długosz J W, Nowak K, Andrzejewska A, Wróblewski E, Dabrowski A
Department of Gastroenterology and Internal Medicine, Medical University of Białystok, Poland.
Rocz Akad Med Bialymst. 2004;49:85-92.
To assess the effect of endothelins: ET-1, ET-2 and ET-3 on trypsinogen activation, lipase activity and histological changes in the pancreas in early (4 hrs) cerulein acute pancreatitis (AP) in rats.
In 45 Wistar rats with cerulein induced AP (2 x 40 microg/kg i.p. at 1 hour interval, the effect of endothelins at the dose 2 x 0.5 or 2 x 1.0 nmol/kg i.p. was assessed vs untreated AP; 6 healthy rats were control (C). Free active trypsin (FAT), total potential trypsin after activation with enterokinase (TPT), lipase in 12000 xg supernatants of pancreatic homogenates and the plasma alpha-amylase were assayed. The %FAT/TPT was an index of trypsinogen activation.
%FAT/TPT increased from 3.0 +/- 0.6 in C to 16.2 +/- 3.1 in AP (p < 0.01). ET-1 decreased this index to 4.8 +/- 1.1 after higher dose (p < 0.01); the effect of lower dose was insignificant. Attenuating effect of ET-2 was significant: 7.3 +/- 1.7 after higher dose (p < 0.05) and 6.1 +/- 0.9 after lower dose (p < 0.01). ET-3 diminished this index to 4.5 +/- 1.5 (p < 0.01) and to 6.3 +/- 2.2 (p < 0.05) respectively. Lipase activity in supernatant increased from 4.1 +/- 0.6 in C to 6.3 +/- 0.7 U/mg protein in untreated AP (p < 0.05) and plasma alpha-amylase from 7.0 +/- 0.6 in C to 25.9 +/- 4.3 U/ml in AP (p < 0.001), without essential changes in treated groups vs untreated AP. Higher doses of endothelins decreased inflammatory cell infiltration score in AP.
The exogenous endothelins, especially ET-2 and ET-3 and to lesser extent ET-1 exerted some protective effect in early, edematous acute pancreatitis by the attenuation of trypsinogen activation and inflammatory cell infiltration in the pancreas.
评估内皮素-1(ET-1)、内皮素-2(ET-2)和内皮素-3(ET-3)对大鼠早期(4小时)蛙皮素诱导的急性胰腺炎(AP)中胰蛋白酶原激活、脂肪酶活性及胰腺组织学变化的影响。
45只经蛙皮素诱导AP的Wistar大鼠(1小时间隔腹腔注射2×40μg/kg),评估腹腔注射剂量为2×0.5或2×1.0nmol/kg的内皮素与未治疗的AP相比的效果;6只健康大鼠作为对照(C)。检测胰腺匀浆12000×g上清液中的游离活性胰蛋白酶(FAT)、用肠激酶激活后的总潜在胰蛋白酶(TPT)、脂肪酶以及血浆α-淀粉酶。FAT/TPT百分比是胰蛋白酶原激活的指标。
FAT/TPT百分比在对照组(C)中为3.0±0.6,在AP组中升至16.2±3.1(p<0.01)。高剂量ET-1使该指标降至4.8±1.1(p<0.01);低剂量效果不显著。ET-2的减轻作用显著:高剂量后为7.3±1.7(p<0.05),低剂量后为6.1±0.9(p<0.01)。ET-3分别使该指标降至4.5±1.5(p<0.01)和6.3±2.2(p<0.05)。上清液中的脂肪酶活性在对照组(C)中为4.1±0.6,在未治疗的AP组中升至6.3±0.7U/mg蛋白(p<0.05),血浆α-淀粉酶在对照组(C)中为7.0±0.6,在AP组中升至25.9±4.3U/ml(p<0.001),治疗组与未治疗的AP组相比无本质变化。高剂量内皮素降低了AP中的炎症细胞浸润评分。
外源性内皮素,尤其是ET-2和ET-3,以及程度较轻的ET-1,通过减轻胰蛋白酶原激活和胰腺中的炎症细胞浸润,在早期水肿性急性胰腺炎中发挥了一定的保护作用。